60 Million Doses of the COVID-19 Vaccine is Added to Moderna’s Supply Agreement with the UK
Moderna’s agreement with the UK government includes 29 million COVID-19 vaccine doses for delivery in 2022 and 31 million doses for delivery in 2023.
Moderna announced on Dec. 1, 2021, a revised supply agreement with the UK government for the company’s COVID-19 vaccine and possibly authorized booster vaccine candidates as well. Specifically, this supply agreement encompasses up to 60 million doses of Moderna’s COVID-19 vaccine.
In 2022, as many as 29 million doses are expected to be delivered, and up to 31 million doses are expected to be delivered in 2023. The UK government retains a right to increase or decrease its purchases in 2022 and 2023, under to the agreement, by up to 20% above or below the contracted volumes.
“We thank the UK government for their support in this supply agreement for our mRNA COVID-19 vaccine and booster candidates, if approved, in 2022 and 2023,” said Stéphane Bancel, CEO of Moderna, in a company press release. “This agreement reflects the efforts of the UK government to address the ongoing pandemic and builds on our existing collaboration to protect people in the UK.”
Source: Moderna
